Litcius/Paper detail

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

Julien Mazières, Claire Cropet, Laure Montané, Fabrice Barlési, P.-J. Souquet, Xavier Quantin, Catherine Dubos‐Arvis, Josiane Otto, Laure Favier, Virginie Avrillon, J. Cadranel, Denis Moro‐Sibilot, I. Monnet, Virginie Westeel, J. Le Treut, Étienne Brain, Jean Trédaniel, M. Jaffro, S. Collot, G. Ferretti, Céline Tiffon, Céline Mahier‐Ait Oukhatar, Jean‐Yves Blay

2020Annals of Oncology189 citationsDOI

Topics & Concepts

VemurafenibMedicineInternal medicineOncologyCohortLung cancerTrametinibDabrafenibCancerMetastatic melanomaBiologyKinaseMAPK/ERK pathwayCell biologyMelanoma and MAPK PathwaysLung Cancer Treatments and MutationsNF-κB Signaling Pathways